Interleukin‐23 inhibition for the treatment of psoriasis: the next frontier for high‐efficacy biologic therapy

E-ISSN： 1365-2133|173|4|887-888

ISSN： 0007-0963

Source： BRITISH JOURNAL OF DERMATOLOGY, Vol.173, Iss.4, 2015-10, pp. : 887-888

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biologic Therapy in Psoriasis: Safety Profile

Current Drug Safety, Vol. 11, Iss. 1, 2016-03 ,pp. : 4-11

Bentham Science Publishers

Access to resources Recommend Favorite

The efficacy of a health‐related quality‐of‐life intervention during 48 weeks of biologic treatment of patients with moderate to severe psoriasis: results of a multicentre randomized controlled trial

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 4, 2015-10 ,pp. : 1091-1094

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical impact of concomitant immunomodulators on biologic therapy: Pharmacokinetics, immunogenicity, efficacy and safety

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. S3, 2015-03 ,pp. : S60-S74

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mixed treatment comparison of efficacy and tolerability of biologic agents in patients with rheumatoid arthritis

By Hochberg Marc C. Berry Scott Broglio Kristine Rosenblatt Lisa Nadkarni Anagha Trivedi Digisha Hebden Tony

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1213-1222

Informa Healthcare

Access to resources Recommend Favorite

The impact of biologic therapy in chronic plaque psoriasis from a societal perspective: an analysis based on Italian actual clinical practice

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 12, 2015-12 ,pp. : 2411-2416

John Wiley & Sons Inc

Access to resources Recommend Favorite